AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265,410 | -66.4% | 25,018 | -68.9% | 0.00% | -66.7% |
| Q2 2023 | $3,761,533 | +66783.6% | 80,564 | +54705.4% | 0.01% | – |
| Q1 2023 | $5,624 | -99.9% | 147 | -99.9% | 0.00% | -100.0% |
| Q4 2022 | $6,829,614 | +341380.7% | 124,628 | +226496.4% | 0.02% | – |
| Q3 2022 | $2,000 | -75.0% | 55 | -93.1% | 0.00% | – |
| Q2 2022 | $8,000 | -94.0% | 800 | -91.5% | 0.00% | – |
| Q1 2022 | $133,000 | -89.6% | 9,400 | -78.6% | 0.00% | -100.0% |
| Q1 2021 | $1,273,000 | +63550.0% | 43,885 | +66392.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -96.4% | 66 | -97.0% | 0.00% | – |
| Q2 2020 | $55,000 | -24.7% | 2,204 | -35.9% | 0.00% | -100.0% |
| Q1 2020 | $73,000 | – | 3,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |